Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON - The Lancet Respiratory Medicine
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results - Journal of Allergy and Clinical Immunology
Disposition for all patients entering the open-label extension (OLE)... | Download Scientific Diagram
Study design of BLISS-SC trial and subsequent open-label extension... | Download Scientific Diagram
Flow chart showing the study design of the open-label extension phase... | Download Scientific Diagram
Use Extension Studies To Enhance Phase 3 Data
Design of the lurasidone open-label core and extension switch studies.*... | Download Scientific Diagram
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program - ScienceDirect
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology
HUMIRA (adalimumab) Open Label Extension Clinical Trial
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial - The Lancet Rheumatology
Spotlight on Open-Label Extension Studies
Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjögren's Syndrome – Open-label Extension Phase of a Randomized Controlled Phase III Trial - ACR Meeting Abstracts
Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf
Flow chart showing the study design of the open-label extension phase... | Download Scientific Diagram
Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram
Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram
Open-label Extension Analysis – OCALIVA® (obeticholic acid) | Official US HCP Site
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine
Figure 8, Study Design of Phase II Open-Label Extension (LSBL99) - Clinical Review Report: Belimumab (Benlysta) - NCBI Bookshelf
Open-Label Extension Studies | SpringerLink
HIV Incidence and Adherence in DREAM -An Open-Label Trial of Dapivirine Vaginal Ring - 2016 / 2018
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine
Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial - Devinsky - 2019 - Epilepsia - Wiley Online Library
OLES Definition: Open Label Extension Study | Abbreviation Finder
Overall study design of phase B (open-label extension) | Download Scientific Diagram
